376,000 Shares in Dominari Holdings Inc. $DOMH Acquired by Creek Drive Management Group LLC

Creek Drive Management Group LLC bought a new stake in shares of Dominari Holdings Inc. (NASDAQ:DOMHFree Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 376,000 shares of the company’s stock, valued at approximately $1,861,000. Dominari accounts for approximately 1.3% of Creek Drive Management Group LLC’s portfolio, making the stock its 25th biggest holding. Creek Drive Management Group LLC owned about 2.32% of Dominari as of its most recent SEC filing.

Several other large investors also recently modified their holdings of DOMH. Two Sigma Investments LP bought a new position in Dominari in the 3rd quarter valued at about $771,000. Renaissance Technologies LLC acquired a new position in shares of Dominari in the 4th quarter valued at approximately $412,000. Connective Capital Management LLC lifted its holdings in shares of Dominari by 26.2% during the 3rd quarter. Connective Capital Management LLC now owns 335,273 shares of the company’s stock worth $2,377,000 after acquiring an additional 69,545 shares during the period. Susquehanna Advisors Group Inc. bought a new stake in shares of Dominari during the 4th quarter worth approximately $182,000. Finally, Millennium Management LLC acquired a new stake in shares of Dominari during the 3rd quarter worth approximately $213,000. 42.48% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded Dominari from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Get Our Latest Report on DOMH

Dominari Stock Performance

DOMH stock opened at $3.37 on Friday. The stock has a market capitalization of $76.20 million, a P/E ratio of -0.84 and a beta of 0.80. Dominari Holdings Inc. has a 12 month low of $2.68 and a 12 month high of $8.40. The firm has a 50-day moving average price of $3.20 and a 200-day moving average price of $3.56.

Dominari (NASDAQ:DOMHGet Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($2.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($1.94). The company had revenue of $35.81 million for the quarter, compared to the consensus estimate of $35.80 million. Dominari had a negative net margin of 31.37% and a negative return on equity of 206.20%.

Dominari Announces Dividend

The business also recently announced a special dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, May 15th.

Dominari Company Profile

(Free Report)

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.

Featured Articles

Want to see what other hedge funds are holding DOMH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dominari Holdings Inc. (NASDAQ:DOMHFree Report).

Institutional Ownership by Quarter for Dominari (NASDAQ:DOMH)

Receive News & Ratings for Dominari Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dominari and related companies with MarketBeat.com's FREE daily email newsletter.